Rosini Jamie M, Davis Joshua J, Muenzer Jeffrey, Levine Brian J, Papas Mia A, Comer Dominique, Arnold Ryan
Department of Pharmacy, Christiana Care Health System, Newark, DE.
Department of Emergency Medicine, Christiana Care Health System, Newark, DE.
Acad Emerg Med. 2016 Jun;23(6):744-6. doi: 10.1111/acem.12934. Epub 2016 May 14.
Vancomycin loading doses are recommended; however, the risk of nephrotoxicity with these doses is unknown. The primary objective of this study was to compare nephrotoxicity in emergency department (ED) sepsis patients who received vancomycin at high doses (>20 mg/kg) versus lower doses (≤20 mg/kg).
A retrospective cohort study was performed in three academic EDs. Inclusion criteria were age ≥ 18 years, intravenous vancomycin order, and hospital admission. Exclusion criteria were no documented weight, hemodialysis-dependent, and inadequate serum creatinine (SCr) values for the measured outcome. Analyses compared the incidence of nephrotoxicity for patients who received vancomycin at high dose (>20 mg/kg) versus low dose (≤20 mg/kg).
A total of 2,131 consecutive patients prescribed vancomycin over 6 months were identified. Of these, 1,330 patients had three SCr values assessed for the primary outcome. High-dose initial vancomycin was associated with a significantly lower rate of nephrotoxicity (5.8% vs. 11.1%). After age, sex, and initial SCr were adjusted for, the risk of high-dose vancomycin compared to low-dose was decreased for the development of nephrotoxicity (relative risk = 0.60; 95% confidence interval = 0.44 to 0.82).
Initial dosing of vancomycin > 20 mg/kg was not associated with an increased rate of nephrotoxicity compared with lower doses. Findings from this study support compliance with initial weight-based vancomycin loading doses.
推荐使用万古霉素负荷剂量;然而,这些剂量导致肾毒性的风险尚不清楚。本研究的主要目的是比较在急诊科(ED)接受高剂量(>20mg/kg)万古霉素与低剂量(≤20mg/kg)的脓毒症患者的肾毒性。
在三家学术性急诊科进行了一项回顾性队列研究。纳入标准为年龄≥18岁、静脉使用万古霉素医嘱以及住院。排除标准为无体重记录、依赖血液透析以及所测结果的血清肌酐(SCr)值不充分。分析比较了接受高剂量(>20mg/kg)与低剂量(≤20mg/kg)万古霉素患者的肾毒性发生率。
共识别出6个月内连续使用万古霉素的2131例患者。其中,1330例患者有三次评估的SCr值用于主要结局。高剂量初始万古霉素与显著较低的肾毒性发生率相关(5.8%对11.1%)。在对年龄、性别和初始SCr进行校正后,高剂量万古霉素与低剂量相比,发生肾毒性的风险降低(相对风险=0.60;95%置信区间=0.44至0.82)。
与较低剂量相比,初始剂量>20mg/kg的万古霉素与肾毒性发生率增加无关。本研究结果支持遵循基于初始体重的万古霉素负荷剂量。